Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
As a GLP-1 medicine, Wegovy carries a boxed warning about a rare thyroid tumor seen in animal studies and is not suitable for anyone with a history of medullary thyroid cancer or MEN 2. Available on prescription
free-drug occupancy method (albumin Kd 1.86 uM, free fraction 0.29%): Willard JCI Insight 2020
Orforgliprons oral delivery route and scalable production capacity position it as a frontrunner in democratizing access to incretin-based therapies, particularly for patients who are hesitant or unable to adhere to injectable regimens
Business Type Supplier, Trading Company Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27DJUPK4957A1ZT Trusted Seller Accepts only Foreign inquiries Shop No-10, Ground Floor, Gokul Ganga-2, B Wing, Near Mittal Enclave, Naigaon E, Vasai, Maharashtra, 401208, India Compare With Similar Products Price Or Price Range 20900.0 INR (Approx.) 3800 INR (Approx.) 300 INR (Approx.) Minimum Order Quantity 100 Piece/Pieces 10 Box/Boxes as per requirement Box/Boxes Indication Indicated for glycemic control in adult patients with Type 2 diabetes mellitus For use in various cancers including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer
Thyroid Concerns Semaglutide carries a boxed warning about thyroid C-cell tumors based on animal studies
Table of Contents: Will I notice a decrease in my appetite immediately after my first semaglutide injection
US$ 26.19
US$ 27.78
US$ 22.16
